TLDR: BullFrog AI Holdings, Inc. will present its bfPREP™ data preparation solution at the AI Drug Discovery & Development Summit 2025 in Boston, Massachusetts. The presentation, titled “Human-in-the-Loop Agent Workflows with bfPREP™,” will detail how the company operationalizes AI agents for reliable and reproducible data analytics in life sciences, aiming to accelerate AI adoption in the biopharma industry.
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company, has announced its participation in the AI Drug Discovery & Development Summit 2025, scheduled for November 18–20, 2025, in Boston, Massachusetts. The company is set to deliver a technical talk titled “Human-in-the-Loop Agent Workflows with bfPREP™” during Technical Insights Session 1 on Wednesday, November 19, 2025.
The presentation will focus on the bfPREP™ data preparation solution, highlighting how it operationalizes AI agents for real-world analytics. This innovative approach aims to transform theoretical AI demonstrations into dependable and reproducible workflows for organizations within the life sciences sector.
Vin Singh, CEO of BullFrog AI, underscored the critical need for reliability in AI applications. “AI agents can be powerful tools, but reliability in production depends on disciplined engineering and quality control,” Singh stated. He further elaborated that bfPREP™ makes “human-in-the-loop AI practical for pharmaceutical data operations, enabling structured outputs, stable schemas, and consistent performance across large, complex datasets.” Singh emphasized that the technology is “not just theoretical; it’s being deployed in real-world drug development environments in order to help clients accelerate analytics and make better decisions faster.” He also expressed his belief that as the company expands its BullFrog Data Networks™ platform, bfPREP™ “could play a defining role in scaling AI adoption across the biopharma industry.”
bfPREP™ is an integral data cleansing and preparation module within BullFrog AI’s broader BullFrog Data Networks™ Solutions Library. Tailored specifically for the life sciences industry, bfPREP™ automates the detection, correction, and standardization of diverse data types, including clinical, omics, and real-world data, effectively converting fragmented information into actionable insights.
The AI Drug Discovery & Development Summit, now in its fourth year, is recognized as a premier global event for innovators leveraging AI throughout the pharmaceutical value chain, from initial discovery to clinical trials. The 2025 summit is anticipated to draw over 500 attendees and feature more than 100 expert speakers, with sessions designed to push the boundaries of AI-driven innovation in drug discovery and development.
Also Read:
- Insilico Medicine to Showcase Advanced Generative AI Platform and Breakthrough Pulmonary Fibrosis Research at PFF Summit 2025
- ISG to Convene AI Impact Summit: Industry Leaders to Discuss Agentic AI Adoption and Governance
BullFrog AI positions itself as an emerging digital biopharma company dedicated to improving drug development and clinical trials through the application of artificial intelligence and machine learning. The company utilizes causal AI in conjunction with its proprietary bfLEAP® platform to analyze complex biological data, with the overarching goal of streamlining therapeutics development and reducing clinical trial failure rates.
